25.1K
Downloads
592
Episodes
Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
Episodes
Oct 19, 2022
Oct 19, 2022
13 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 19, 2022
Oct 19, 2022
11 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 19, 2022
Oct 19, 2022
9 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 19, 2022
Oct 19, 2022
10 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 19, 2022
Oct 19, 2022
14 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 18, 2022
Oct 18, 2022
9 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 18, 2022
Oct 18, 2022
16 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 18, 2022
Oct 18, 2022
10 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 18, 2022
Oct 18, 2022
11 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.
Oct 18, 2022
Oct 18, 2022
9 min
Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.